By: Quiver InsiderRadar, Automated
Posted: an hour ago / April 24, 2026 10:27 p.m. UTC
We estimate that the President, CEO, and Director of Sana Biotechnology, Inc. ($SANA), Steven D. Harr, M.D., received a compensation of $2,903,010 in 2025. This is a decrease of -202.74% from an estimated $8,788,580 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 24, 2026. Note that parsing errors may occur.
You can track $SANA on Quiver Quantitative’s $SANA stock dashboard.
$SANA Stock Hedge Fund Activity
We have seen 104 institutional investors add shares of $SANA Stock stock to their portfolio, and 79 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC removed 6,538,436 shares (-99.8%) from their portfolio in Q4 2025, for an estimated $26,611,434
- BAILLIE GIFFORD & CO removed 4,827,438 shares (-42.2%) from their portfolio in Q4 2025, for an estimated $19,647,672
- BLACKROCK, INC. added 2,997,391 shares (+26.7%) to their portfolio in Q4 2025, for an estimated $12,199,381
- BAKER BROS. ADVISORS LP removed 1,720,466 shares (-84.7%) from their portfolio in Q4 2025, for an estimated $7,002,296
- BALYASNY ASSET MANAGEMENT L.P. added 1,679,130 shares (+inf%) to their portfolio in Q4 2025, for an estimated $6,834,059
- STATE STREET CORP added 1,374,300 shares (+20.6%) to their portfolio in Q4 2025, for an estimated $5,593,401
- VANGUARD GROUP INC added 1,326,222 shares (+14.5%) to their portfolio in Q4 2025, for an estimated $5,397,723
To track hedge funds’ stock portfolios, check out Quiver Quantitative’s institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
$SANA Stock Analyst Ratings
Wall Street analysts have issued reports on $SANA in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a “Buy” rating on 01/06/2026
- HC Wainwright & Co. issued a “Buy” rating on 11/07/2025
- Wedbush issued a “Outperform” rating on 11/07/2025
- Citizens issued a “Market Outperform” rating on 10/30/2025
To track analyst ratings and price targets for $SANA Stock, check out Quiver Quantitative’s $SANA forecast page.
$SANA Stock Price Targets
Multiple analysts have issued price targets for $SANA recently. We have seen 4 analysts offer price targets for $SANA in the last 6 months, with a median target of $7.0.
Here are some recent targets:
- Martin Fan from Wedbush set a target price of $7.0 on 04/14/2026
- Emily Bodnar from HC Wainwright & Co. set a target price of $7.0 on 03/04/2026
- An analyst from B of A Securities set a target price of $7.0 on 01/06/2026
- Reni J. Benjamin from Citizens set a target price of $8.0 on 10/30/2025
This article is not financial advice. See Quiver Quantitative’s disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.